R&D Why the best CROs challenge the trial plan and keep challeng... Too often, oncology trials fail for reasons that could have been anticipated and addressed.
Digital Building an AI-native CRO Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.
R&D Trial complexity is the new normal When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
R&D When metrics measure more than they improve The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"
R&D How automation can drive a competitive advantage for CROs & ... For CROs and CDMOs, automation is key to ensuring long-term success.
R&D Navigating the new ICH E6 (R3): Key changes for sponsors These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.